1. People's Republic of China Stocks

  2. •

    Healthcare

  3. •

    Medical - Healthcare Information Services
Winning Health Technology Group Co., Ltd.

Winning Health Technology Group Co., Ltd.

300253.SZ
Winning Health Technology Group Co., Ltd.CN flagShenzhen Stock Exchange
6.54
CNY
-0.28
- -
14.40BMarket Cap
Winning Health Technology Group Co., Ltd.
300253.SZ
(Shenzhen Stock Exchange)

Recent

price

6.54

P/E

ratio

- -

div

yld

- -

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
FRC
0.09
0.11
0.14
0.19
0.26
0.4
0.48
0.58
0.69
0.91
1.07
1.28
1.45
1.47
1.29
0.95
1.09
Revenue per Share
0.03
0.03
0.03
0.04
0.06
0.08
0.26
0.11
0.15
0.19
0.23
0.18
0.05
0.17
0.04
-0.17
-0.03
Basic EPS, GAAP
0.03
-0.01
0.01
0.02
0.01
-0.08
-0.1
-0.04
-0.02
0.02
0.1
0.04
-0.1
-0.06
0.05
0.15
-0.12
Free Cash Flow per Basic Share
0.01
- -
- -
- -
0.01
0.02
0.03
0.03
0.02
0.02
0.02
0.03
0.02
0.01
0.03
0.02
0.02
Dividend per Share
0.05
0.08
0.12
0.16
0.26
0.44
0.69
1.12
1.27
1.42
1.84
1.96
1.99
2.13
2.16
1.94
2.06
Book Value per Share
0.07
0.31
0.28
0.34
0.26
0.32
0.91
0.95
1.2
1.39
1.59
1.68
1.57
1.72
1.8
1.65
1.72
Tangible Book Value per Share
1,389
1,531
1,864
1,834
1,873
1,895
1,998
2,069
2,079
2,102
2,125
2,143
2,139
2,147
2,154
2,210
2,204
Basic Weighted Avg Shares
120
170
266
349
491
753
954
1,204
1,439
1,908
2,267
2,750
3,093
3,163
2,782
2,106
2,398
Sales/Revenue/Turnover
23.57
19.36
12.17
15.56
19.96
17.16
19.88
27.11
26.82
26.98
27.82
19.89
14.26
17.66
17.16
-2.71
15.05
Operating Margin (%)
1
1
4
7
8
13
14
25
29
52
63
100
117
173
186
226
- -
Depreciation Expense
35
44
53
81
121
153
519
229
303
398
491
378
109
358
88
-374
-60
Net Income, GAAP
9.27
9.7
9.13
6.83
4.93
- -
9.94
10.34
0.87
4.13
7.44
5.21
61.71
6.79
42.42
- -
- -
Effective Tax Rate (%)
29.4
26.07
19.89
23.11
24.62
20.25
54.34
19.03
21.08
20.88
21.67
13.75
3.51
11.32
3.16
-17.75
-2.51
Profit Margin (%)
92
462
505
575
511
301
694
754
1,166
1,508
1,998
2,901
2,729
3,146
3,450
3,185
3,335
Working Capital
- -
- -
- -
- -
94
64
36
18
- -
1
6
920
975
1,019
1,066
1,113
1,081
LT Debt
95
478
532
630
792
1,048
2,407
2,659
3,332
3,916
4,714
5,173
5,127
5,681
5,934
5,596
5,848
Total Equity
29.57
10.4
5.93
8.95
12.07
- -
8.25
10.37
12.21
13.45
13.16
9.51
2.81
8.15
4.04
- -
- -
Return on Invested Capital (%)
50.04
39.86
25.44
29.3
25.1
- -
35.81
10.68
11.09
12.95
12.59
9.35
4.26
8.3
2.86
- -
- -
Return on Capital (%)
50.63
43.31
29.91
31.32
30.98
23.07
46.91
12.41
12.27
14.18
14.25
9.32
2.56
8.09
1.9
-8.36
-1.32
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Dec'24
Mar'25
Jun'25
ST Debt
92
84
58
LT Borrowings
1,052
1,062
1,077
LT Finance Leases
14
16
5
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
2,191
2,212
2,213
Market Capitalization
15,455
23,802
23,362

Working Capital

FRC

•

in mil. unless spec.
Dec'24
Mar'25
Jun'25
Total Current Assets
5,095
4,946
4,840
Cash, Cash Equivalents & STI
1,339
1,337
1,334
Accounts Receivable, Net
1,193
1,037
1,000
Inventories
111
115
123
Total Current Liabilities
1,646
1,442
1,505
Payables & Accruals
- -
- -
- -
ST Debt
92
84
58
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
22.18%
3.68%
-5.7%
Free Cash Flow
-31.17%
-84.95%
229.38%
Net Income, GAAP
-19.43%
-93.12%
-525.38%
Sales/Revenue/Turnover
12.35%
-0.05%
-24.3%
Total Cash Common Dividend
13.75%
9.54%
-11.19%

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
494
729
690
869
2,782
2025
345
494
810
- -
2,106
2026
397
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.01
- -
- -
- -
0.04
2025
- -
- -
- -
- -
-0.17
2026
0.01
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
0.03
2025
0.01
- -
- -
- -
0.02
2026
0.01
- -
- -
- -
- -
Similar Companies
eWellness Healthcare Corp. (EWLL)
Alkuri Global Acquisition Corp. (KURIU)
Aspyra Inc. (APYI)
Jayex Technology Limited (JTL.AX)
MSP Recovery, Inc. (LIFWW)
Mednow Inc. (MNOW.V)
Business
Winning Health Technology Group Co., Ltd. (300253.SZ) provides digital health services and healthcare information technology solutions to medical institutions and health organizations primarily in China. The company develops and offers core products including the WiNEX digital health platform; smart hospital solutions encompassing hospital information systems, electronic medical records, and electronic medical records application level 5 and above certifications; smart regional healthcare platforms for community, public health, and medical insurance regulation; Internet+ healthcare and telemedicine services; and WinCloud, a cloud-based delivery, operation, and maintenance management platform. Additional offerings cover IT solution design, planning, consulting, development, system integration, maintenance, and operation services tailored for smart hospitals and regional healthcare ecosystems. Founded in 1994 and headquartered in Shanghai, China, the company operates mainly across China with recent expansion into international markets, including the launch of the Macau Union Medical College Hospital project. It targets hospitals, regional health authorities, and health professionals, serving numerous tertiary hospitals and focusing on sectors such as medical informatization, commercial insurance, and intelligent healthcare ecosystems. In recent developments, the company increased its stake in subsidiary Huan Yao Weining Health Insurance Technology (Shanghai) Co., Ltd. through equity transfers and capital injections totaling approximately RMB 18.4 million in registered capital, raising its ownership from 42.5% to 78.6% as of early 2025 to enhance control and operational funding. Shanghai Kingstar Winning Software Technology Co., Ltd., a key subsidiary, introduced new strategic investors including Taiping (Shenzhen) Medical Health Industry Private Equity Fund and Taicang Kaihui Growth No. 2 Investment Fund via equity transfers and capital expansion to bolster commercial/medical insurance intelligent risk control and data businesses. In February 2025, it released upgraded products WingPt 2.8 and WineX Copilot 2.1, an AI-powered intelligent healthcare assistant integrated with DeepSeek, alongside ongoing R&D investments at 20.2% of 2024 revenue focused on WineX, AI applications, and over 600 Xinchuang (secure and controllable) certifications. The company reported 2024 revenue of RMB 2.78 billion, down 12% year-over-year, with Q1 2025 revenue at RMB 340 million, amid transitions to next-generation products like WinEx.